Previous 10 | Next 10 |
NOTE: ADUHELM TM (aducanumab-avwa) injection 100 mg/mL solution is indicated for the treatment of Alzheimer’s disease. Treatment with ADUHELM should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which tr...
Biogen (BIIB): Q2 Non-GAAP EPS of $5.68 beats by $1.08; GAAP EPS of $2.99 misses by $1.27.Revenue of $2.78B (-24.5% Y/Y) beats by $170M.FY21 Guidance: Revenue to be $10.65B-$10.85B from prior guidance of $10.45B-$10.75B vs. consensus of $10.64B. Adj. EPS of $17.50-$19...
Meme stock Cassava Sciences Inc. ( NASDAQ:SAVA ) shares surged more than 27% on Wednesday after revealing plans to present data on its Alzheimer’s drug, Simufilam, on 29th July. Cassava will read out its interim analysis on a 9-month treatment with Simulflam at the 2021 A...
Shares of Cassava Sciences (NASDAQ: SAVA) , a clinical-stage biopharmaceutical company, gained 26.6% as of 3:05 p.m. EDT on Wednesday. Investors are anticipating a new set of clinical-trial data from the company's lead candidate, simufilam, to be presented at the Alzheimer's Associa...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you thought Reddit stocks were nearing the end of their usefulness, think again. The slump seen across plays like AMC (NYSE: AMC ) plagued the class of securities in the last few weeks, but it is looking sma...
Biogen (BIIB) and Mirimus have entered into a strategic collaboration focused on the development of RNAi-based therapeutics targeting multiple, undisclosed neurological disease indications.Further financial details of the deal were not disclosed.Under the agreement, Mirimus will app...
Mirimus, Inc. Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications PR Newswire NEW YORK , July 21, 2021 /PRNewswire/ -- Mirimus, Inc., a pioneer in RNAi therapeutic design and CRISPR/Cas9 gene editing t...
Investing in biotechnology companies can be a risky proposition. Regulatory setbacks or negative results from clinical trials are sometimes enough to send shares falling off a cliff. But biotech companies can also offer explosive growth, provided you pick the right ones. And before investin...
Cassava is dramatically undervalued. Cassava is addressing the largest unmet need in the healthcare industry. Cassava’s Simufilam has unprecedented and consistent data with a flawless safety profile, and a unique mechanism of action. Simufilam is a better product, with ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
As the market runs into rough weather, the importance of the upcoming week’s earnings cannot be emphasized enough. A lot is riding on the ear...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...